Comparison of anastomotic patency and remnant pancreatic function between invagination and duct-to-mucosa pancreaticojejunostomy: A follow-up study of a randomized trial.
Hidenori Ojio, Seiji Natsume, Yasuhiro Shimizu et al.
✦ AI-curated · Sources linked
In 30 seconds
This study compared long-term anastomotic patency and remnant pancreatic function between invagination and duct-to-mucosa pancreaticojejunostomy in 120 patients post-pancreatoduodenectomy. The results indicated no significant differences in benign remnant pancreatic duct dilatation (18.6% vs 9.8%, P = .262) or cumulative incidences of benign anastomotic stricture between the two techniques.
Key findings
- Benign remnant pancreatic duct dilatation occurred in 18.6% of invagination patients versus 9.8% in duct-to-mucosa patients (P = .262).
- The 3-year cumulative incidence of benign anastomotic stricture was 9.3% for invagination and 9.5% for duct-to-mucosa (P = .356).
- Remnant pancreatic volume, fatty liver disease, and type 2 diabetes incidence were similar between both surgical techniques.
Why it matters
Understanding the long-term outcomes of different surgical techniques for pancreaticojejunostomy is crucial for optimizing patient care after pancreatoduodenectomy. This study provides insights into the comparative effectiveness of these methods regarding anastomotic patency and pancreatic function.